Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma
NCT05527106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73
Last updated 2022-09-02
Summary
Pilot, single-blind, randomized and controlled study to evaluate the changes produced in the visual function of patients with glaucoma after oral administration for 3 months of citicoline and docosahexaenoic Acid (DHA) vs citicoline and docosahexaenoic Acid (DHA) vs vitamin C.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Citicoline
Every subject randomized into this group have to take 2 sachets of Cebrolux 800 (362 mg of citicoline per day), every day, for 3 months.
- DIETARY_SUPPLEMENT
-
Docosahexaenoic Acid (DHA)
Every subject randomized into this group have to take 3 pills of Brudypio 1.5g (1050 mg of DHA per day), every day, for 3 months.
- DIETARY_SUPPLEMENT
-
Citicoline and Docosahexaenoic Acid (DHA)
Every subject randomized into this group have to take 2 sachets of Cebrolux 800 and 3 pills of Brudypio 1.5g per day, every day, for 3 months.
- DIETARY_SUPPLEMENT
-
Vitamin C
Every subject randomized into this group have to take 1 pills of Vitamin C (500 mg per day), every day, for 3 months.
Sponsors & Collaborators
-
Institut Catala de Retina
lead OTHER
Principal Investigators
-
Alfonso Anton, MD, PhD · Institut Catala de Retina
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 50 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-12
- Primary Completion
- 2022-05-25
- Completion
- 2022-05-25
Countries
- Spain
Study Locations
More Related Trials
-
Impact of Oral Versatile Antioxidants on Glaucoma Progression
NCT01544192 ·Status: COMPLETED ·Phase: PHASE3
-
Valuation of the Antioxidant and Neuroprotective Effects of CoQ10-MINIACTIVES® (COQUN® OS) in Patients Affected by Primary Open Angle Glaucoma
NCT04038034 ·Status: UNKNOWN ·Phase: NA
-
Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin
NCT04784234 ·Status: TERMINATED ·Phase: NA
-
Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Treatment With Either Beta-blockers or Prostaglandins Eye Drops
NCT00863811 ·Status: WITHDRAWN
-
Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients
NCT01262209 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Procedure for Previously Failed Glaucoma Surgery
NCT00347789 ·Status: COMPLETED
-
Effects of Forskolin on Intraocular Pressure in Glaucomatous Patients Under Maximum Tolerated Medical Therapy
NCT00864578 ·Status: WITHDRAWN
-
AI for the Detection of Retinal Disease and Glaucoma in Patients With Diabetes Mellitus in Primary Care
NCT04132401 ·Status: COMPLETED ·Phase: NA
-
Nicotinamide Levels in Serum, Aqueous Humor, and Tear Film in Glaucoma and Correlations With Mitochondrial Damage-Associated Molecular Patterns (mtDAMPs) and Senescence-Associated Secretory Phenotype (SASP)
NCT07006194 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of Outcome and Effectiveness Between Micropulse Diode Laser Cyclophotocoagulation and Cyclocryoablation in Treatment of Refractory Glaucoma
NCT05437614 ·Status: UNKNOWN ·Phase: NA
-
Glaucoma Screening With Smartphone Ophthalmology
NCT02520674 ·Status: COMPLETED ·Phase: NA
-
Effect of Niacinamide Supplementation in Glaucoma
NCT07007260 ·Status: COMPLETED ·Phase: NA
-
Comparative Effectiveness and Tolerance of Subliminal Subthreshold Transscleral Cyclophotocoagulation
NCT03961035 ·Status: COMPLETED
-
Nicotinamide and Glaucoma
NCT05916066 ·Status: COMPLETED ·Phase: NA
-
The Effect of Direct Cyclophotocoagulation Using Endolaser in Silicon Induced Glaucoma: a Pilot Study.
NCT05231252 ·Status: COMPLETED ·Phase: NA
-
Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients
NCT06991712 ·Status: RECRUITING ·Phase: PHASE2
-
STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient
NCT05747781 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Canadian Glaucoma Study
NCT00262626 ·Status: TERMINATED ·Phase: NA
-
The Effects of Changing Light Levels on Contrast Sensitivity in Patients With Glaucoma
NCT04061343 ·Status: COMPLETED
-
Laser Dosage in MicroPulse TransScleral CycloPhotocoagulation
NCT04709679 ·Status: TERMINATED ·Phase: NA
-
Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma
NCT00476138 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Exercise Intervention in Primary Open-angle Glaucoma
NCT05704777 ·Status: UNKNOWN ·Phase: NA
-
How Has Glaucoma Affected Your Quality of Life?
NCT01476644 ·Status: COMPLETED ·Phase: NA
-
The Antioxidant Effect of Routine Vascular Therapy for Normal Tension Glaucoma Patients
NCT00465348 ·Status: WITHDRAWN
-
Impact of Glaucoma and Visual Field Loss on Life Space
NCT03673644 ·Status: ACTIVE_NOT_RECRUITING